omega-n-methylarginine has been researched along with fk 409 in 6 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (fk 409) | Trials (fk 409) | Recent Studies (post-2010) (fk 409) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 146 | 0 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuichi, A; Isono, T; Kohsaka, M; Koibuchi, Y; Mori, J; Nishii, M; Ohtsuka, M; Sato, N; Yamamoto, T | 1 |
| Barnes, PJ; Khawaja, AM; Ramnarine, SI; Rogers, DF | 1 |
| Best, PJ; Holmes, DR; Lerman, A; Lerman, LO; Richardson, DM; Wilson, SH | 1 |
| Hiraga, H; Okubo, T; Okumura, K; Suto, N; Yamamoto, T; Yoshida, IM | 1 |
| Kyo, E; Moriguchi, T; Morihara, N; Sumioka, I; Uda, N | 1 |
| Azuma, H; Hirata, Y; Imamura, M; Sakurada, M; Shichiri, M | 1 |
6 other study(ies) available for omega-n-methylarginine and fk 409
| Article | Year |
|---|---|
Vasorelaxant mechanism of the new vasodilator, FK409.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Nitroglycerin; omega-N-Methylarginine; Oxyhemoglobins; Rabbits; Rats; Rats, Sprague-Dawley; Solubility; Vasodilator Agents | 1993 |
Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro.
Topics: Animals; Arginine; Ferrets; In Vitro Techniques; Male; Mucus; Nitric Oxide; Nitric Oxide Synthase; Nitro Compounds; omega-N-Methylarginine; Trachea | 1996 |
Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Analysis of Variance; Animals; Arginine; Arteries; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Vessels; Dinoprost; Dinoprostone; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Unsaturated; Female; Hydrazines; Hypercholesterolemia; Immunohistochemistry; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitro Compounds; omega-N-Methylarginine; Oxidative Stress; Random Allocation; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Nitric oxide donor FK409 and 8-bromoguanosine-cyclic monophosphate attenuate cardiac contractility assessed by Emax.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Myocardial Contraction; Myocardium; Nitric Oxide Donors; Nitro Compounds; omega-N-Methylarginine; Papaverine; Propranolol; Vasodilation; Vasodilator Agents; Ventricular Function, Left | 2001 |
Aged garlic extract enhances production of nitric oxide.
Topics: Animals; Enzyme Inhibitors; Garlic; Lipopolysaccharides; Male; Mice; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Nitro Compounds; omega-N-Methylarginine; Onium Compounds; Plant Extracts; Time Factors | 2002 |
Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Topics: Amidohydrolases; Animals; Arginine; Carbazoles; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Male; Natriuretic Peptide, C-Type; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitro Compounds; omega-N-Methylarginine; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Up-Regulation | 2008 |